22 November 2017
News and Views
Links and Services
The latest European Journal of Gastroenterology & Hepatology evaluated host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
The burden of hepatitis C virus genotype 4 (HCV-4) is high in Africa and East Mediterranean count
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors